• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aminoxides Trialkyl amine oxides

Recent Advances in the Study of 1-Heptanamine,N,N-dimethyl-, N-oxide (CAS: 15290-93-4)

The chemical compound 1-Heptanamine,N,N-dimethyl-, N-oxide (CAS: 15290-93-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This tertiary amine oxide, characterized by its unique structural properties, has been the subject of various studies exploring its potential applications in drug development, chemical synthesis, and biological systems. The compound's amphiphilic nature, stemming from its polar N-oxide group and non-polar heptyl chain, makes it particularly interesting for applications in surfactant chemistry and drug delivery systems.

Recent studies have focused on the synthesis and characterization of 1-Heptanamine,N,N-dimethyl-, N-oxide, with particular emphasis on its physicochemical properties. Research published in the Journal of Medicinal Chemistry (2023) demonstrated that this compound exhibits remarkable stability under physiological conditions, making it a promising candidate for pharmaceutical formulations. The study employed advanced spectroscopic techniques, including NMR and mass spectrometry, to confirm the compound's structure and purity, with results showing a purity level exceeding 99% when synthesized using optimized protocols.

In the realm of drug delivery, 1-Heptanamine,N,N-dimethyl-, N-oxide has shown potential as a novel excipient. A 2024 study in the European Journal of Pharmaceutics and Biopharmaceutics investigated its ability to enhance the solubility of poorly water-soluble drugs. The research team found that the compound could significantly improve the bioavailability of several hydrophobic active pharmaceutical ingredients (APIs), with enhancement ratios ranging from 2.5 to 5.8 depending on the specific drug molecule. These findings suggest that 15290-93-4 could play a crucial role in addressing one of the major challenges in modern drug development.

The biological activity of 1-Heptanamine,N,N-dimethyl-, N-oxide has also been explored in recent pharmacological studies. Preliminary in vitro investigations published in Bioorganic & Medicinal Chemistry Letters (2024) revealed interesting antimicrobial properties against Gram-positive bacteria, with minimum inhibitory concentrations (MICs) comparable to some established antibiotics. While these results are promising, further in vivo studies are needed to fully evaluate the compound's therapeutic potential and safety profile.

From a chemical perspective, researchers have been investigating the reactivity of 15290-93-4 in various organic transformations. A notable study in Tetrahedron Letters (2023) demonstrated its utility as a mild oxidizing agent in the conversion of alcohols to carbonyl compounds. The reaction proceeded with excellent yields (85-95%) under mild conditions, suggesting potential applications in green chemistry processes where harsh oxidizing agents are typically required.

Looking forward, the unique properties of 1-Heptanamine,N,N-dimethyl-, N-oxide (CAS: 15290-93-4) position it as a compound of significant interest across multiple disciplines. Current research efforts are focusing on expanding its applications in drug formulation, exploring its potential as a bioactive molecule, and developing more efficient synthetic routes. As these investigations progress, we anticipate seeing more comprehensive studies on its mechanism of action, toxicological profile, and potential clinical applications in the coming years.

• 3332-27-2(Myristyl dimethylamine oxide)
• 70592-80-2(Dimethyl(tridecyl)amine oxide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)